Aarti Drugs Ltd
NSE: AARTIDRUGS BSE: 524348
₹367
(-0.65%)
Wed, 11 Mar 2026, 01:55 am
Market Cap33.5B
PE Ratio16.53
Dividend0.54
Health Technology
Pharmaceuticals: Major
24.5KCompany History
1981
- Mr. P.M. Patil and Mr. S. P. Nachane joined the Group
1984
- Aarti Drugs Limited was incorporated on 28th September as a Private Limited Company
1987
- The Company started its commercial production in March at G.I.D.C. Industrial Estate, Sarigam, Dist. Valsad, Gujarat
1990
- The Company has maintained an unbroken dividend record since the year 1990-91
1991
- The Alchemie Group recorded an export turnover of more than Rs. 30 crores
- The Group's turnover and profits have increased five-fold in the last 5 years
1992
- Aarti Drugs Limited was converted into a Public Limited Company on 1st July
2000
- The Company proposed to acquire 15,31,000 No. of equity shares of Alchemie Organics Ltd
2002
- Gauri Balankhe appointed as Compliance Officer of Aarti Drugs
2004
- Aarti Drugs Ltd. has changed its Registrar and Share Transfer Agent and Depository interface for Handling Depository related operations by appointing M/s Sharepro Services
- Aarti bags European certification for three drugs
- Delist from Ahmedabad Stock Exchange (ASE) with effect from October 15, 2004
2006
- Aarti Drugs enters into JV with API Manufacturing Chinese Company
- Mr. Prakash Khedekar, Company Secretary & Compliance Officer of the Company has resigned from the position of Company Secretary & Compliance Officer
- Mrs. Mona Patel, has been appointed as Company Secretary & Compliance Officer of the Company
2009
- Aarti Drugs Ltd has appointed Shri Krishnacharya Govindacharya Akamanchi & Prof. Sudhir Prakash B. Sawant as Independent Directors of the Company
2010
- Aarti Drugs has recommended dividend of Rs. 5/- (50%) per share
2011
- Mr. Sunny D. Pagare, has been appointed as Company Secretary & Compliance Officer of the Company
- Aarti Drugs has recommended Final Dividend of Rs. 2.5 /-per share (25%)
2012
- Mr. Adhish P. Patil, has been appointed as Chief Financial Officer of the Company
- Aarti Drugs has declared Final dividend Rs. 3.00 (30%) per share
2013
- Aarti Drugs has recommended a Final Dividend of Rs. 4/- per share on Equity Shares of Rs. 10/- each
2014
- Aarti Drugs has commenced the new R&D center at MIDC Tarapur
- Aarti Drugs has recommended a Final dividend @ Rs. 5.50 ps. (55%) per share
2015
- Aarti Drugs Ltd will participate at 'Centrum Pharma Day' Investor Conference
- The Company has allotted the Bonus Shares to its shareholders in the Ratio of 1:1
2020
- The Company has issued Bonus Shares in the Ratio of 3:1
2023
- Aarti Drugs Limited won Pharmexcil Outstanding Exports Awards 2021-22
2024
- The Company Initiating Commercial Production of Dermatology Product at New Facility in Tarapur, Maharashtra
2025
- Aarti Drugs Limited has informed the Exchange about Commencement of commercial production/operation.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800